Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Varicose Ulcer | 24 | 2021 | 54 | 5.390 |
Why?
|
Varicose Veins | 22 | 2020 | 158 | 5.220 |
Why?
|
Venous Insufficiency | 20 | 2024 | 111 | 5.140 |
Why?
|
Glycosaminoglycans | 7 | 2024 | 606 | 2.430 |
Why?
|
Vena Cava, Inferior | 10 | 2020 | 463 | 2.210 |
Why?
|
Vasodilation | 9 | 2019 | 970 | 1.790 |
Why?
|
Vasoconstriction | 10 | 2020 | 594 | 1.760 |
Why?
|
Aortic Aneurysm, Abdominal | 13 | 2022 | 1211 | 1.250 |
Why?
|
E-Selectin | 2 | 2022 | 576 | 1.230 |
Why?
|
Saphenous Vein | 5 | 2024 | 511 | 1.220 |
Why?
|
Vasoconstrictor Agents | 10 | 2020 | 655 | 1.130 |
Why?
|
Femoral Artery | 6 | 2016 | 811 | 1.120 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2020 | 462 | 1.100 |
Why?
|
Venous Thrombosis | 6 | 2022 | 1327 | 1.100 |
Why?
|
Wound Healing | 11 | 2017 | 2792 | 1.090 |
Why?
|
Matrix Metalloproteinases | 7 | 2017 | 392 | 1.060 |
Why?
|
Matrix Metalloproteinase 9 | 4 | 2024 | 636 | 1.060 |
Why?
|
Leg | 5 | 2021 | 1080 | 1.050 |
Why?
|
Veins | 5 | 2017 | 764 | 0.980 |
Why?
|
Blood Vessel Prosthesis Implantation | 10 | 2022 | 1434 | 0.980 |
Why?
|
Leg Ulcer | 2 | 2016 | 70 | 0.970 |
Why?
|
Iliac Vein | 3 | 2023 | 73 | 0.840 |
Why?
|
Muscle, Smooth, Vascular | 8 | 2016 | 1499 | 0.840 |
Why?
|
Vascular Diseases | 5 | 2023 | 1159 | 0.790 |
Why?
|
Fibroblasts | 10 | 2009 | 4159 | 0.790 |
Why?
|
Arterial Occlusive Diseases | 5 | 2016 | 729 | 0.780 |
Why?
|
Lower Extremity | 8 | 2023 | 1226 | 0.730 |
Why?
|
Aneurysm | 2 | 2017 | 337 | 0.720 |
Why?
|
Endothelium, Vascular | 5 | 2019 | 4427 | 0.710 |
Why?
|
Vascular Surgical Procedures | 10 | 2022 | 1485 | 0.680 |
Why?
|
Chronic Disease | 23 | 2024 | 9347 | 0.640 |
Why?
|
Nitric Oxide | 5 | 2019 | 2143 | 0.640 |
Why?
|
Stockings, Compression | 4 | 2020 | 37 | 0.610 |
Why?
|
Leukocytes | 4 | 2017 | 2027 | 0.590 |
Why?
|
Endovascular Procedures | 8 | 2024 | 2222 | 0.580 |
Why?
|
Endarterectomy, Carotid | 2 | 2022 | 557 | 0.570 |
Why?
|
Peripheral Vascular Diseases | 4 | 2010 | 516 | 0.530 |
Why?
|
Thrombophlebitis | 3 | 2014 | 286 | 0.530 |
Why?
|
Phenylephrine | 8 | 2016 | 292 | 0.510 |
Why?
|
Intermittent Claudication | 4 | 2016 | 300 | 0.490 |
Why?
|
Glycocalyx | 1 | 2016 | 98 | 0.470 |
Why?
|
Portal Vein | 1 | 2017 | 435 | 0.470 |
Why?
|
Carotid Stenosis | 1 | 2022 | 861 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1808 | 0.460 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2013 | 208 | 0.450 |
Why?
|
Iliac Artery | 3 | 2016 | 330 | 0.440 |
Why?
|
Colony-Stimulating Factors | 1 | 2014 | 218 | 0.430 |
Why?
|
Anticoagulants | 3 | 2020 | 4862 | 0.430 |
Why?
|
Potassium Chloride | 6 | 2011 | 229 | 0.420 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 2 | 2016 | 97 | 0.410 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 683 | 0.400 |
Why?
|
Calcium Signaling | 3 | 2011 | 733 | 0.390 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 35 | 0.380 |
Why?
|
Aneurysm, Infected | 1 | 2012 | 82 | 0.380 |
Why?
|
Venous Pressure | 2 | 2008 | 55 | 0.380 |
Why?
|
Cardiovascular Agents | 3 | 2014 | 851 | 0.380 |
Why?
|
Escin | 1 | 2011 | 2 | 0.380 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 19 | 0.380 |
Why?
|
Aneurysm, Ruptured | 1 | 2016 | 456 | 0.370 |
Why?
|
Rats, Sprague-Dawley | 9 | 2020 | 8102 | 0.370 |
Why?
|
Vasodilator Agents | 5 | 2011 | 988 | 0.360 |
Why?
|
Endarterectomy | 1 | 2011 | 186 | 0.360 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1030 | 0.360 |
Why?
|
Biological Factors | 1 | 2011 | 155 | 0.360 |
Why?
|
Microcirculation | 2 | 2015 | 1280 | 0.350 |
Why?
|
Aortic Diseases | 4 | 2016 | 729 | 0.340 |
Why?
|
Axillary Artery | 2 | 2016 | 48 | 0.330 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2019 | 10729 | 0.320 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.320 |
Why?
|
Aneurysm, False | 2 | 2011 | 264 | 0.320 |
Why?
|
Angioplasty | 1 | 2011 | 352 | 0.310 |
Why?
|
Skin | 4 | 2013 | 4489 | 0.310 |
Why?
|
Tunica Intima | 1 | 2011 | 455 | 0.310 |
Why?
|
Seat Belts | 1 | 2008 | 60 | 0.300 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 150 | 0.290 |
Why?
|
Muscle Contraction | 3 | 2020 | 1206 | 0.290 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 437 | 0.280 |
Why?
|
Femoral Vein | 2 | 2020 | 157 | 0.280 |
Why?
|
Cytokines | 5 | 2016 | 7421 | 0.280 |
Why?
|
Blood Vessel Prosthesis | 3 | 2022 | 912 | 0.270 |
Why?
|
Humans | 86 | 2024 | 765968 | 0.270 |
Why?
|
Angiotensin II | 4 | 2011 | 844 | 0.270 |
Why?
|
Treatment Outcome | 25 | 2024 | 65188 | 0.270 |
Why?
|
Quadriplegia | 1 | 2008 | 227 | 0.260 |
Why?
|
Laser Therapy | 1 | 2013 | 1108 | 0.260 |
Why?
|
Collagenases | 2 | 2016 | 221 | 0.250 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 705 | 0.250 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2006 | 615 | 0.240 |
Why?
|
Metabolome | 1 | 2012 | 1005 | 0.240 |
Why?
|
Male | 56 | 2024 | 363698 | 0.240 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 691 | 0.240 |
Why?
|
Osteosarcoma | 1 | 2011 | 909 | 0.240 |
Why?
|
Metabolomics | 1 | 2014 | 1668 | 0.230 |
Why?
|
Signal Transduction | 7 | 2019 | 23601 | 0.230 |
Why?
|
Potassium Channels | 1 | 2007 | 534 | 0.220 |
Why?
|
Aorta, Abdominal | 2 | 2004 | 596 | 0.220 |
Why?
|
Vertebral Artery Dissection | 1 | 2004 | 48 | 0.220 |
Why?
|
Rats | 8 | 2019 | 23707 | 0.220 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 874 | 0.220 |
Why?
|
Membrane Potentials | 3 | 2011 | 1083 | 0.220 |
Why?
|
Risk Factors | 22 | 2024 | 74840 | 0.220 |
Why?
|
Cell Proliferation | 4 | 2009 | 10429 | 0.220 |
Why?
|
Inflammation | 3 | 2016 | 10850 | 0.210 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1393 | 0.210 |
Why?
|
Terminology as Topic | 1 | 2010 | 1534 | 0.210 |
Why?
|
U937 Cells | 2 | 2014 | 259 | 0.210 |
Why?
|
Abdominal Abscess | 1 | 2004 | 152 | 0.210 |
Why?
|
Cross Infection | 1 | 2012 | 1427 | 0.210 |
Why?
|
Endothelial Cells | 1 | 2016 | 3584 | 0.210 |
Why?
|
Hernia | 1 | 2003 | 67 | 0.210 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2016 | 235 | 0.200 |
Why?
|
Nitric Oxide Synthase | 3 | 2011 | 911 | 0.200 |
Why?
|
Cell Division | 5 | 2004 | 4475 | 0.200 |
Why?
|
Hospital Costs | 1 | 2008 | 956 | 0.200 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3672 | 0.200 |
Why?
|
Anesthesia, Local | 1 | 2024 | 276 | 0.190 |
Why?
|
Lymphedema | 2 | 2022 | 525 | 0.190 |
Why?
|
Mutation, Missense | 1 | 2011 | 2589 | 0.190 |
Why?
|
Constriction, Pathologic | 2 | 2018 | 1105 | 0.190 |
Why?
|
Surgical Wound Dehiscence | 1 | 2003 | 215 | 0.190 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2242 | 0.190 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2024 | 694 | 0.190 |
Why?
|
Blood Vessels | 1 | 2007 | 1113 | 0.190 |
Why?
|
Sclerotherapy | 2 | 2014 | 184 | 0.190 |
Why?
|
Lipids | 1 | 2012 | 3315 | 0.180 |
Why?
|
Anesthesia, Conduction | 1 | 2024 | 264 | 0.180 |
Why?
|
Baroreflex | 1 | 2022 | 153 | 0.180 |
Why?
|
Laparotomy | 1 | 2003 | 460 | 0.180 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8529 | 0.170 |
Why?
|
Animals | 21 | 2020 | 168764 | 0.170 |
Why?
|
Proteomics | 1 | 2014 | 3910 | 0.170 |
Why?
|
Cyclic GMP | 2 | 2011 | 394 | 0.170 |
Why?
|
Fluid Shifts | 1 | 2020 | 20 | 0.170 |
Why?
|
Receptors, Adrenergic, alpha | 2 | 2010 | 146 | 0.170 |
Why?
|
Popliteal Artery | 1 | 2002 | 301 | 0.170 |
Why?
|
Down-Regulation | 2 | 2020 | 2927 | 0.170 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2011 | 153 | 0.170 |
Why?
|
Sarcoma | 1 | 2011 | 1802 | 0.160 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2008 | 594 | 0.160 |
Why?
|
Hernia, Ventral | 1 | 2003 | 220 | 0.160 |
Why?
|
P-Selectin | 1 | 2022 | 597 | 0.160 |
Why?
|
Flavonoids | 2 | 2017 | 448 | 0.160 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1053 | 0.160 |
Why?
|
Prosthesis-Related Infections | 1 | 2004 | 496 | 0.160 |
Why?
|
Potassium Channel Blockers | 2 | 2011 | 162 | 0.160 |
Why?
|
Catheterization, Central Venous | 1 | 2004 | 539 | 0.160 |
Why?
|
Cardiology | 3 | 2022 | 1702 | 0.160 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1311 | 0.160 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2002 | 290 | 0.160 |
Why?
|
Ischemia | 2 | 2019 | 1909 | 0.160 |
Why?
|
Macrophages | 1 | 2014 | 5772 | 0.160 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1490 | 0.150 |
Why?
|
Extracellular Fluid | 1 | 2020 | 165 | 0.150 |
Why?
|
Genomics | 1 | 2014 | 5929 | 0.150 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2010 | 261 | 0.150 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1884 | 0.150 |
Why?
|
Middle Aged | 31 | 2024 | 223009 | 0.150 |
Why?
|
Aged | 29 | 2024 | 171117 | 0.150 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2011 | 361 | 0.140 |
Why?
|
Carotid Arteries | 1 | 2022 | 929 | 0.140 |
Why?
|
Compression Bandages | 2 | 2014 | 14 | 0.140 |
Why?
|
Anesthesia, General | 1 | 2024 | 1172 | 0.140 |
Why?
|
Postthrombotic Syndrome | 2 | 2014 | 30 | 0.140 |
Why?
|
Fatal Outcome | 2 | 2012 | 1831 | 0.140 |
Why?
|
Organ Culture Techniques | 1 | 2019 | 788 | 0.130 |
Why?
|
Cell Movement | 2 | 2016 | 5194 | 0.130 |
Why?
|
Aortography | 2 | 2012 | 414 | 0.130 |
Why?
|
Female | 38 | 2024 | 396112 | 0.130 |
Why?
|
Hemodynamics | 3 | 2017 | 4184 | 0.130 |
Why?
|
Cytoskeleton | 1 | 2001 | 1178 | 0.130 |
Why?
|
Time Factors | 13 | 2024 | 40065 | 0.130 |
Why?
|
Cells, Cultured | 9 | 2024 | 18973 | 0.130 |
Why?
|
Ligation | 1 | 2016 | 444 | 0.130 |
Why?
|
Dilatation, Pathologic | 2 | 2008 | 527 | 0.130 |
Why?
|
Stents | 4 | 2023 | 3213 | 0.130 |
Why?
|
Walking | 2 | 2020 | 1198 | 0.120 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 3715 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2015 | 2059 | 0.120 |
Why?
|
Postoperative Complications | 7 | 2024 | 15747 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 460 | 0.120 |
Why?
|
Veterans Health | 1 | 2016 | 216 | 0.120 |
Why?
|
Actins | 1 | 2001 | 2056 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2011 | 11641 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15398 | 0.100 |
Why?
|
Spine | 1 | 2020 | 1128 | 0.100 |
Why?
|
Choice Behavior | 1 | 2019 | 844 | 0.100 |
Why?
|
Immunohistochemistry | 4 | 2011 | 11022 | 0.100 |
Why?
|
Prostaglandins I | 1 | 2011 | 12 | 0.100 |
Why?
|
Probability | 3 | 2010 | 2475 | 0.100 |
Why?
|
Tuberculosis | 1 | 2004 | 2012 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4209 | 0.090 |
Why?
|
Diosmin | 1 | 2011 | 6 | 0.090 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2011 | 18 | 0.090 |
Why?
|
Patient Preference | 1 | 2019 | 952 | 0.090 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2011 | 42 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 7 | 2012 | 20659 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3432 | 0.090 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2011 | 110 | 0.090 |
Why?
|
Isometric Contraction | 2 | 2008 | 149 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 633 | 0.090 |
Why?
|
Pressoreceptors | 1 | 2010 | 98 | 0.090 |
Why?
|
Risk Assessment | 11 | 2024 | 24282 | 0.090 |
Why?
|
Observer Variation | 1 | 2017 | 2615 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1370 | 0.090 |
Why?
|
Evidence-Based Medicine | 4 | 2015 | 3685 | 0.090 |
Why?
|
Body Composition | 1 | 2020 | 2439 | 0.090 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 891 | 0.090 |
Why?
|
Prognosis | 5 | 2019 | 29922 | 0.090 |
Why?
|
Prospective Studies | 9 | 2020 | 54802 | 0.080 |
Why?
|
Apoptosis | 2 | 2008 | 9514 | 0.080 |
Why?
|
Receptors, Angiotensin | 1 | 2010 | 141 | 0.080 |
Why?
|
Logistic Models | 5 | 2023 | 13266 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1995 | 0.080 |
Why?
|
Estrogen Antagonists | 1 | 2010 | 150 | 0.080 |
Why?
|
Chemokines | 1 | 2014 | 956 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18071 | 0.080 |
Why?
|
Resistin | 1 | 2010 | 174 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 171 | 0.080 |
Why?
|
Sodium Chloride, Dietary | 1 | 2011 | 303 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2003 | 0.080 |
Why?
|
Thrombectomy | 2 | 2012 | 681 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2011 | 707 | 0.080 |
Why?
|
Autopsy | 1 | 2012 | 1011 | 0.080 |
Why?
|
Vascular Patency | 1 | 2011 | 912 | 0.070 |
Why?
|
Prosthesis Design | 2 | 2022 | 2105 | 0.070 |
Why?
|
Nitriles | 2 | 2010 | 982 | 0.070 |
Why?
|
Wheelchairs | 1 | 2008 | 78 | 0.070 |
Why?
|
Acetylcholine | 1 | 2010 | 626 | 0.070 |
Why?
|
Reference Values | 2 | 2008 | 4908 | 0.070 |
Why?
|
Adult | 17 | 2024 | 223044 | 0.070 |
Why?
|
Scleroderma, Localized | 1 | 2008 | 85 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2008 | 508 | 0.070 |
Why?
|
Cromakalim | 1 | 2007 | 23 | 0.070 |
Why?
|
Odds Ratio | 5 | 2022 | 9649 | 0.070 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2007 | 43 | 0.070 |
Why?
|
Tissue Culture Techniques | 1 | 2008 | 286 | 0.070 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2007 | 21 | 0.070 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 238 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 618 | 0.070 |
Why?
|
Biopsy | 2 | 2011 | 6763 | 0.070 |
Why?
|
Hospital Charges | 1 | 2008 | 345 | 0.070 |
Why?
|
Indomethacin | 1 | 2007 | 322 | 0.070 |
Why?
|
Acute Disease | 3 | 2012 | 7232 | 0.060 |
Why?
|
Hyperemia | 1 | 2007 | 224 | 0.060 |
Why?
|
Caveolin 1 | 1 | 2008 | 255 | 0.060 |
Why?
|
Phenols | 1 | 2010 | 522 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 81514 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2216 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2017 | 22223 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3807 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 578 | 0.060 |
Why?
|
Epoprostenol | 1 | 2007 | 246 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1657 | 0.060 |
Why?
|
Brachial Artery | 1 | 2007 | 375 | 0.060 |
Why?
|
Mechanotransduction, Cellular | 1 | 2010 | 540 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1776 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2006 | 173 | 0.060 |
Why?
|
Incidental Findings | 1 | 2010 | 697 | 0.060 |
Why?
|
Tuberculosis, Cardiovascular | 1 | 2004 | 8 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 372 | 0.060 |
Why?
|
Immunoblotting | 1 | 2008 | 1644 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 637 | 0.060 |
Why?
|
Leukemia | 1 | 2013 | 1522 | 0.060 |
Why?
|
Collagen | 1 | 2013 | 2618 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2008 | 746 | 0.060 |
Why?
|
Pressure | 1 | 2008 | 1168 | 0.060 |
Why?
|
Rifabutin | 1 | 2004 | 52 | 0.060 |
Why?
|
Thigh | 1 | 2006 | 238 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1140 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4058 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 396 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2008 | 1243 | 0.060 |
Why?
|
Age Factors | 3 | 2017 | 18380 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2008 | 426 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2006 | 330 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1426 | 0.060 |
Why?
|
Adiponectin | 1 | 2010 | 1119 | 0.060 |
Why?
|
Popliteal Vein | 1 | 2023 | 45 | 0.050 |
Why?
|
Random Allocation | 1 | 2008 | 2395 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1275 | 0.050 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59489 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2011 | 15880 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2004 | 324 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2008 | 623 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 612 | 0.050 |
Why?
|
Estrogens | 1 | 2010 | 1529 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1308 | 0.050 |
Why?
|
Takayasu Arteritis | 1 | 2004 | 104 | 0.050 |
Why?
|
Oligopeptides | 1 | 2008 | 1192 | 0.050 |
Why?
|
Isoniazid | 1 | 2004 | 281 | 0.050 |
Why?
|
Up-Regulation | 2 | 2010 | 4137 | 0.050 |
Why?
|
Jugular Veins | 1 | 2004 | 211 | 0.050 |
Why?
|
Vascular Fistula | 1 | 2003 | 50 | 0.050 |
Why?
|
Societies, Medical | 2 | 2014 | 3956 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1947 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2008 | 1191 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10383 | 0.050 |
Why?
|
Duodenal Diseases | 1 | 2003 | 101 | 0.050 |
Why?
|
Retinoblastoma Protein | 1 | 2006 | 666 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 1242 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2080 | 0.050 |
Why?
|
Imidazoles | 1 | 2008 | 1162 | 0.050 |
Why?
|
Tibial Arteries | 1 | 2002 | 60 | 0.050 |
Why?
|
Polyethylene Terephthalates | 1 | 2002 | 109 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14652 | 0.050 |
Why?
|
Hypertension | 3 | 2017 | 8626 | 0.050 |
Why?
|
Intestinal Fistula | 1 | 2003 | 146 | 0.050 |
Why?
|
Debridement | 1 | 2004 | 495 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2598 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1727 | 0.050 |
Why?
|
Regional Blood Flow | 2 | 2019 | 1478 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2008 | 5696 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6919 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3853 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2024 | 676 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3529 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1375 | 0.040 |
Why?
|
Disease Progression | 2 | 2012 | 13632 | 0.040 |
Why?
|
Phosphorylation | 2 | 2008 | 8278 | 0.040 |
Why?
|
Patient Selection | 3 | 2022 | 4255 | 0.040 |
Why?
|
Length of Stay | 2 | 2016 | 6485 | 0.040 |
Why?
|
Fibronectins | 2 | 2003 | 719 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3242 | 0.040 |
Why?
|
Pyrazoles | 1 | 2010 | 2033 | 0.040 |
Why?
|
Extracellular Space | 1 | 2001 | 563 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 704 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12976 | 0.040 |
Why?
|
Device Removal | 1 | 2004 | 646 | 0.040 |
Why?
|
Drainage | 1 | 2004 | 1179 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1999 | 368 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5876 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5020 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 1999 | 572 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4588 | 0.040 |
Why?
|
Blood Pressure | 2 | 2011 | 8532 | 0.040 |
Why?
|
Dyslipidemias | 1 | 2005 | 869 | 0.040 |
Why?
|
Information Seeking Behavior | 1 | 2019 | 116 | 0.040 |
Why?
|
Propensity Score | 2 | 2016 | 1968 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 893 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2002 | 589 | 0.040 |
Why?
|
Pericardium | 1 | 2002 | 679 | 0.040 |
Why?
|
Streptonigrin | 1 | 1997 | 1 | 0.040 |
Why?
|
Pre-Eclampsia | 1 | 2007 | 1261 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15842 | 0.030 |
Why?
|
Breast Neoplasms, Male | 1 | 1999 | 212 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4348 | 0.030 |
Why?
|
Blood Loss, Surgical | 2 | 2016 | 629 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12056 | 0.030 |
Why?
|
Pyridines | 1 | 2008 | 2888 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10603 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2001 | 1628 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2004 | 1384 | 0.030 |
Why?
|
Cell Death | 1 | 2001 | 1679 | 0.030 |
Why?
|
Palliative Care | 1 | 2011 | 3645 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2844 | 0.030 |
Why?
|
Electric Impedance | 1 | 2020 | 794 | 0.030 |
Why?
|
Permeability | 1 | 2017 | 726 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4331 | 0.030 |
Why?
|
United States | 6 | 2022 | 72903 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3222 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39193 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1731 | 0.030 |
Why?
|
Capillaries | 1 | 2017 | 755 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7478 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2004 | 1917 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 679 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2005 | 2495 | 0.030 |
Why?
|
Edema | 1 | 2017 | 760 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 59889 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1718 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18293 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2108 | 0.030 |
Why?
|
Pneumonia | 1 | 2004 | 2157 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4562 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3202 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3424 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1668 | 0.020 |
Why?
|
Echinomycin | 1 | 2010 | 2 | 0.020 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 934 | 0.020 |
Why?
|
Cell Cycle | 1 | 1999 | 2920 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1999 | 6203 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Guanylate Cyclase | 1 | 2011 | 205 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 8067 | 0.020 |
Why?
|
Benzoquinones | 1 | 2010 | 198 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3247 | 0.020 |
Why?
|
Renin | 1 | 2011 | 647 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2010 | 318 | 0.020 |
Why?
|
Thrombosis | 1 | 2003 | 2949 | 0.020 |
Why?
|
Smoking | 1 | 2005 | 9081 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2011 | 328 | 0.020 |
Why?
|
Adipokines | 1 | 2010 | 308 | 0.020 |
Why?
|
Muscle Relaxation | 1 | 2008 | 138 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3770 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 2163 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2499 | 0.020 |
Why?
|
Algorithms | 2 | 2005 | 14071 | 0.020 |
Why?
|
Aldosterone | 1 | 2011 | 881 | 0.020 |
Why?
|
Cyclin D | 1 | 2006 | 70 | 0.020 |
Why?
|
Reoperation | 1 | 2016 | 4294 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13451 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 30260 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 1103 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2120 | 0.010 |
Why?
|
Angiography | 1 | 2010 | 1581 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5089 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2910 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2010 | 12768 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14448 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12509 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8731 | 0.010 |
Why?
|
Cyclins | 1 | 2006 | 598 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1381 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15543 | 0.010 |
Why?
|
Hematemesis | 1 | 2003 | 22 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3461 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5343 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15652 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10563 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2001 | 26346 | 0.010 |
Why?
|
Surgical Mesh | 1 | 2002 | 315 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3890 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2002 | 990 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26318 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8501 | 0.010 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 1997 | 158 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4622 | 0.010 |
Why?
|
Methanol | 1 | 1997 | 90 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13024 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6499 | 0.010 |
Why?
|
Drug Stability | 1 | 1997 | 288 | 0.010 |
Why?
|
Solutions | 1 | 1997 | 403 | 0.010 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2003 | 700 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1997 | 251 | 0.010 |
Why?
|
Solvents | 1 | 1997 | 299 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13462 | 0.010 |
Why?
|
Ultrasonography | 1 | 2007 | 5993 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14751 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16721 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81819 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1997 | 2477 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3051 | 0.010 |
Why?
|
Temperature | 1 | 1997 | 2226 | 0.010 |
Why?
|
Diet | 1 | 2008 | 8086 | 0.010 |
Why?
|
Indoles | 1 | 1997 | 1839 | 0.000 |
Why?
|
Incidence | 1 | 1999 | 21480 | 0.000 |
Why?
|